PLoS ONE (Jan 2019)

Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.

  • Georgios Batsos,
  • Eleni Christodoulou,
  • Georgios Vartholomatos,
  • Petros Galanis,
  • Maria Stefaniotou

DOI
https://doi.org/10.1371/journal.pone.0227266
Journal volume & issue
Vol. 14, no. 12
p. e0227266

Abstract

Read online

PurposeTo measure vitreous levels of Lipocalin2 (LCN2) in patients with rhegmatogenous retinal detachment (RRD) and investigate potential association with presence of proliferative vitreoretinopathy (PVR).Materials and methodsCollection of undiluted vitreous samples from 24 patients suffering from RRD and 10 control patients undergoing vitrectomy for: vitreomacular traction (VMT) (n = 2), idiopathic epiretinal membrane (iERM) (n = 6) and full thickness macular hole (FTMH) (n = 2). Quantitative analysis of LCN2 has been made with flow cytometry. Lens status, duration of symptoms, quadrants of detachment, as well as level of PVR, were assessed. Statistical analysis included Mann-Whitney test, Kruskal-Wallis test, t-test, Spearman's correlation coefficient and Fisher's exact test.ResultsMedian LCN2 was significantly higher in the RRD group as compared to control (p2 quadrants, pConclusionA positive correlation between vitreous levels of LCN2 and PVR grading reveals a potential role in the pathogenesis and progression of PVR. Further studies could elucidate if LCN2 could be a therapeutic target.